158 related articles for article (PubMed ID: 18025183)
1. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.
Busconi L; Bauer JW; Tumang JR; Laws A; Perkins-Mesires K; Tabor AS; Lau C; Corley RB; Rothstein TL; Lund FE; Behrens TW; Marshak-Rothstein A
J Immunol; 2007 Dec; 179(11):7397-405. PubMed ID: 18025183
[TBL] [Abstract][Full Text] [Related]
2. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes.
Avalos AM; Kiefer K; Tian J; Christensen S; Shlomchik M; Coyle AJ; Marshak-Rothstein A
Autoimmunity; 2010 Feb; 43(1):103-10. PubMed ID: 20014975
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
4. TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.
Szili D; Bankó Z; Tóth EA; Nagy G; Rojkovich B; Gáti T; Simon M; Hérincs Z; Sármay G
PLoS One; 2014; 9(5):e96381. PubMed ID: 24801688
[TBL] [Abstract][Full Text] [Related]
5. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
6. Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus.
Sang A; Zheng YY; Choi SC; Zeumer L; Morel L
J Leukoc Biol; 2015 Aug; 98(2):209-21. PubMed ID: 25957308
[TBL] [Abstract][Full Text] [Related]
7. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
[TBL] [Abstract][Full Text] [Related]
8. T-bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades.
Kövesdi D; Angyal A; Huber K; Szili D; Sármay G
Eur J Immunol; 2014 Mar; 44(3):887-93. PubMed ID: 24249581
[TBL] [Abstract][Full Text] [Related]
9. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
10. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
Avalos AM; Latz E; Mousseau B; Christensen SR; Shlomchik MJ; Lund F; Marshak-Rothstein A
J Immunol; 2009 Nov; 183(10):6262-8. PubMed ID: 19864612
[TBL] [Abstract][Full Text] [Related]
11. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
12. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
[TBL] [Abstract][Full Text] [Related]
13. Activation of autoreactive B cells by CpG dsDNA.
Viglianti GA; Lau CM; Hanley TM; Miko BA; Shlomchik MJ; Marshak-Rothstein A
Immunity; 2003 Dec; 19(6):837-47. PubMed ID: 14670301
[TBL] [Abstract][Full Text] [Related]
14. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
15. TLR9-mediated signals rescue B-cells from Fas-induced apoptosis via inactivation of caspases.
Hancz A; Koncz G; Szili D; Sármay G
Immunol Lett; 2012 Mar; 143(1):77-84. PubMed ID: 22553782
[TBL] [Abstract][Full Text] [Related]
16. FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.
Avalos AM; Uccellini MB; Lenert P; Viglianti GA; Marshak-Rothstein A
Eur J Immunol; 2010 Oct; 40(10):2692-8. PubMed ID: 20809520
[TBL] [Abstract][Full Text] [Related]
17. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens.
Chaturvedi A; Dorward D; Pierce SK
Immunity; 2008 Jun; 28(6):799-809. PubMed ID: 18513998
[TBL] [Abstract][Full Text] [Related]
18. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
19. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
20. TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.
Guerrier T; Pochard P; Lahiri A; Youinou P; Pers JO; Jamin C
J Autoimmun; 2014 Jun; 51():23-9. PubMed ID: 24582318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
